Event-Driven Stocks

CASI Pharmaceuticals, Inc.

CASIFOTC

Healthcare · Pharmaceutical Preparations · E9 · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 severedetails ↓

Financials

SEC XBRL · annual

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

Signs

● 1 severe● 0 good
  • Filed a late-filing notice (Form NT) — missed an SEC deadline

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026314,13016.3-1.4%
Apr 30, 2026318,5195.1-27.7%
Apr 15, 2026440,78043.4-0.4%
Mar 31, 2026442,45129.0-3.4%
Mar 13, 2026457,9894.8+1.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.